BARBANTI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 15.556
AS - Asia 11.970
EU - Europa 8.925
SA - Sud America 1.774
Continente sconosciuto - Info sul continente non disponibili 503
AF - Africa 147
OC - Oceania 16
Totale 38.891
Nazione #
US - Stati Uniti d'America 15.315
HK - Hong Kong 7.930
IE - Irlanda 5.959
SG - Singapore 2.231
BR - Brasile 1.453
GB - Regno Unito 938
IT - Italia 525
CN - Cina 480
CH - Svizzera 413
VN - Vietnam 395
FI - Finlandia 331
BD - Bangladesh 284
DE - Germania 241
TR - Turchia 159
AR - Argentina 124
IN - India 112
FR - Francia 103
CA - Canada 96
MX - Messico 84
SE - Svezia 62
EC - Ecuador 55
NL - Olanda 54
IQ - Iraq 52
PL - Polonia 50
CO - Colombia 47
EE - Estonia 41
ID - Indonesia 41
RU - Federazione Russa 38
ZA - Sudafrica 38
CZ - Repubblica Ceca 36
UZ - Uzbekistan 33
PK - Pakistan 31
KR - Corea 28
ES - Italia 27
AT - Austria 26
JP - Giappone 25
MA - Marocco 25
PY - Paraguay 23
PH - Filippine 20
CL - Cile 19
EG - Egitto 19
UA - Ucraina 19
UY - Uruguay 19
VE - Venezuela 19
KE - Kenya 17
SA - Arabia Saudita 15
AU - Australia 14
MY - Malesia 14
JM - Giamaica 13
CR - Costa Rica 12
IL - Israele 11
IR - Iran 11
JO - Giordania 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
NP - Nepal 10
PE - Perù 10
TN - Tunisia 10
AZ - Azerbaigian 9
BG - Bulgaria 8
DZ - Algeria 8
TH - Thailandia 8
TW - Taiwan 8
LT - Lituania 7
TT - Trinidad e Tobago 7
HN - Honduras 6
KZ - Kazakistan 6
LV - Lettonia 6
BO - Bolivia 5
LY - Libia 5
OM - Oman 5
AM - Armenia 4
AO - Angola 4
BB - Barbados 4
BE - Belgio 4
BH - Bahrain 4
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KG - Kirghizistan 4
NI - Nicaragua 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
CY - Cipro 3
HU - Ungheria 3
LB - Libano 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
TG - Togo 3
UG - Uganda 3
GD - Grenada 2
GT - Guatemala 2
KH - Cambogia 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BS - Bahamas 1
Totale 38.368
Città #
Hong Kong 7.929
Dallas 6.304
Dublin 5.921
Ashburn 1.608
San Jose 1.593
Singapore 1.074
London 835
Boardman 807
Santa Clara 507
The Dalles 481
Chicago 475
Zurich 406
Helsinki 318
Washington 197
Phoenix 175
Ho Chi Minh City 138
Los Angeles 136
São Paulo 127
Istanbul 115
Beijing 110
New York 95
Hanoi 87
Assago 76
Munich 73
Rio de Janeiro 54
Milan 53
Council Bluffs 51
Rome 48
San Francisco 44
Warsaw 43
Hillsboro 42
Belo Horizonte 38
Orem 36
Frankfurt am Main 35
Montreal 33
Catania 32
Mexico City 32
Brooklyn 31
Seattle 30
Amsterdam 29
Tashkent 28
Chennai 27
Brasília 26
Seoul 25
Guayaquil 22
Porto Alegre 22
Brno 21
Salvador 20
Atlanta 18
Boston 18
Johannesburg 18
Montevideo 18
Naples 18
Stockholm 18
Buffalo 17
Curitiba 17
Manchester 17
Shanghai 17
Da Nang 16
Haiphong 16
Nairobi 16
Quito 16
Hải Dương 15
Mumbai 15
Campinas 14
Olomouc 14
Tokyo 14
Dhaka 13
Falkenstein 13
Buenos Aires 12
Duque de Caxias 12
Goiânia 12
Guarulhos 12
Thái Bình 12
Amman 11
Baghdad 11
Cipolletti 11
Fortaleza 11
Toronto 11
Clifton 10
Genoa 10
Reston 10
Ribeirão Preto 10
Thái Nguyên 10
Turin 10
Turku 10
Addis Ababa 9
Bexley 9
Casablanca 9
Düsseldorf 9
Erbil 9
Guangzhou 9
Jeddah 9
Karachi 9
Kingston 9
Lahore 9
Medellín 9
Miami 9
Piscataway 9
Baku 8
Totale 31.057
Nome #
1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study 2.469
European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease 1.180
Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm 973
Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis 971
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 723
Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: the AVENGER multicentre registry 658
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 584
Embolic protection device in a patient with large left ventricular thrombus undergoing transcatheter aortic valve replacement 567
Predicting neocommissural orientation during TAVI workup 510
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison 497
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement 446
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 395
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 382
Le nuove frontiere della cardiologia interventistica strutturale 360
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT study 149
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 145
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 141
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 139
Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project 136
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update 134
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 131
[Transcatheter aortic valve implantation: are we ready? If so, for which patients? Is it sustainable? The interventional cardiologist's point of view] 129
A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement 127
Antithrombotic therapy following transcatheter aortic valve implantation: what challenge do we face? 126
Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes 126
Transcatheter mitral valve implantation: CardiAQ 122
A minimalistic approach for transfemoral transcatheter aortic valve implantation therapy: a prospective “real-world” study 119
Late Degeneration of Transcatheter Aortic Valves: Pathogenesis and Management 117
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry 116
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantation 115
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation 113
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis 110
5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis 110
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey 109
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 108
ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases 108
5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction 107
Transcatheter aortic valve-in-valve implantation to treat aortic para-valvular regurgitation after TAVI 107
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry 104
Pathophysiology, incidence and predictors of conduction disturbances during Transcatheter Aortic Valve Implantation 102
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration 102
[Evolution of transcatheter aortic valve implantation from a high-volume Italian center: report of 2058 procedures over 15-year experience] 102
Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system 101
Managing complications after transcatheter aortic valve implantation 100
Early Adverse Impact of Transfusion After Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the TRITAVI Registry 100
Transcatheter Mitral Valve Implantation: CardiAQ-Edwards 100
Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry 100
CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry 98
[First results from the OBSERVANT II study: clinical characteristics of patients with aortic stenosis undergoing transcatheter treatment with new generation devices] 98
Early detection of transcatheter heart valve dysfunction 97
Functional and metabolic frailty predicts mortality in patients undergoing TAVI: Insights from the OBSERVANT II study 97
Acute and long-term (2-years) clinical outcomes of the CoreValve 31mm in large aortic annuli: A multicenter study 97
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 96
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation 96
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation 96
Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement 95
Early and late outcomes after transcatheter versus surgical aortic valve replacement in obese patients 94
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 93
Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry 92
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation 92
Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve 91
One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry) 91
Early and Mid-Term Outcomes of Transcatheter Aortic Valve Replacement Using the New Generation Self-Expanding Corevalve Evolut R Device 91
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 90
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 90
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 90
Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis 89
Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison 89
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less 89
The Helio transcatheter aortic dock for patients with aortic regurgitation 89
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation 88
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry 88
Early and mid-term outcome of patients with low-flow-low-gradient aortic stenosis treated with newer-generation transcatheter aortic valves 88
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 88
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation 87
Long-term outcomes of concomitant transcatheter aortic valve implantation and percutaneous coronary intervention 87
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry 87
Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection 87
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis 86
Bioprosthetic valves for transcatheter aortic valve replacement 86
Cerebral embolization during transcatheter aortic valve implantation 86
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation 86
OBSERVANT II: OBservational Study of Effectiveness of transcatheter aortic valve implantation with new geneRation deVices for severe Aortic steNosis Treatment. Study protocol 86
Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves 86
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 85
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in patients with anaemia 85
Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death 85
Outcomes of Patients Undergoing Balloon Aortic Valvuloplasty in the TAVI Era: A Multicenter Registry 85
Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosis 85
Management of severe stenosis controversies and promises 84
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study 84
Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management 84
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes 84
Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement 83
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices 83
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study 83
Severe aortic valve stenosis: Symptoms, biochemical markers, and global longitudinal strain 83
Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort 83
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry 82
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 82
Totale 19.266
Categoria #
all - tutte 185.755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231.386 0 0 0 0 0 0 0 0 0 269 817 300
2023/20247.574 278 707 401 540 1.311 1.170 1.228 492 439 431 249 328
2024/202514.265 1.491 249 544 152 610 681 7.367 307 978 692 766 428
2025/202614.972 870 3.391 3.663 1.212 323 469 1.512 975 991 848 420 298
2026/2027694 224 326 144 0 0 0 0 0 0 0 0 0
Totale 38.891